Publications by authors named "Jose Allue"

Claim this Profile
P
Plasma Aβ42/Aβ40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer's disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort.
Noelia Fandos, María Pascual-Lucas, Leticia Sarasa, Jose Terencio, Mª Eugenia Sáez

J Prev Alzheimers Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study.
María Pascual-Lucas, Ana María Lacosta, María Montañés, Jesús Canudas, Jorge Loscos

Alzheimers Dement· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of a plasma-based antibody-free LC-MS method for identifying CSF amyloid positivity in mild cognitive impairment.
José Antonio Allué, Leticia Sarasa, Noelia Fandos, Ricardo Gonzalo, Rubén Sabido-Vera

Front Aging Neurosci· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[SEFAC 2025 Conference: Community pharmacy facing the challenge of specialisation and change].
Leire Andraca, José Luis Allué

Farm Comunitarios· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study.
José Antonio Allué, María Pascual-Lucas, Leticia Sarasa, Sergio Castillo, Manuel Sarasa

Alzheimers Dement (Amst)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prospective observational study of the impact of problems accessing treatment such as risk factors for adherence and persistence. Pilot study].
Irene Jaraiz Magariños, Alicia F Martínez, Eduardo Satué de Velasco, Eduardo Agustín, José Luis Allué

Farm Comunitarios· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity.
Min Young Chun, Hyemin Jang, Hee Jin Kim, Jun Pyo Kim, John Gallacher

Front Aging Neurosci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Project on exceptional dispensation in the Principality of Asturias].
Irene Jaraiz Magariños, Alicia F Martínez, Eduardo Satué de Velasco, Eduardo Agustín, Silvia López

Farm Comunitarios· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.
María Pascual-Lucas, José Antonio Allué, Leticia Sarasa, Noelia Fandos, Sergio Castillo

Alzheimers Res Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau.
Shorena Janelidze, Sebastian Palmqvist, Antoine Leuzy, Erik Stomrud, Inge M W Verberk

Alzheimers Dement· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.
Shorena Janelidze, Charlotte E Teunissen, Henrik Zetterberg, José Antonio Allué, Leticia Sarasa

JAMA Neurol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort.
Hyemin Jang, Ji Sun Kim, Hye Joo Lee, Chi-Hun Kim, Duk L Na

Alzheimers Res Ther· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations.
Nicholas C Cullen, Antoine Leuzy, Sebastian Palmqvist, Shorena Janelidze, Erik Stomrud

Nat Aging· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
José Antonio Allué, Leticia Sarasa, María Izco, Virginia Pérez-Grijalba, Noelia Fandos

J Alzheimers Dis· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness of Ginger in the Prevention of Nausea and Vomiting during Pregnancy and Chemotherapy.
Iñaki Lete, José Allué

Integr Med Insights· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aβ1-17 is a major amyloid-β fragment isoform in cerebrospinal fluid and blood with possible diagnostic value in Alzheimer's disease.
Virginia Pérez-Grijalba, Pedro Pesini, José Antonio Allué, Leticia Sarasa, María Montañés

J Alzheimers Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of β-amyloid species in canine cerebrospinal fluid by mass spectrometry.
Leticia Sarasa, José Antonio Allué, Pedro Pesini, Angela González-Martínez, Manuel Sarasa

Neurobiol Aging· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis